A new clinical trial has found that doxycycline, a widely available antibiotic, can help prevent already hospitalized COVID-19 patients from worsening to the point where they need intensive care. Sold in the United States under brand names like Acticlate, Vibramycin, and Oracea, doxycycline has been widely used to treat pneumonia caused by bacteria. It is

Leave a Reply